ESC 365 - Impact of sacubitril/valsartan on functional exercise capacity and quality of life in patients with heart failure with reduced ejection fraction

EAPC Premium Access

Impact of sacubitril/valsartan on functional exercise capacity and quality of life in patients with heart failure with reduced ejection fraction

Session: Poster Session 2 - Heart failure

Topic: Chronic Heart Failure, Other

Speaker: Doctor C. Mantis (Athens, GR)

Event: EuroPrevent 2018

Congress Presentation

Add to my library

About the speaker

Doctor Christos Mantis

KAT General Hospital, Athens (Greece)

0 follower

10 more presentations in this session

Heart failure - Poster discussant:

Predictors of mid-term rehospitalizations and mortality rates in Bulgarian patients with HFpEF

Efficacy of long lasting therapy with ramipril and eprosartan on diastolic dysfunction, functional class of HFpEF and insulin resistance in hypertensives

Speaker: Doctor N. Sapojnic (Chisinau, MD)

Effect of individual therapeutic management of new-onset atrial fibrillation for duration of chronic heart failure

Speaker: Associate Professor Y. Shaposhnikova (Kharkiv, UA)

Reverse myocardial remodeling after aerobic training in heart failure patients

Access the full session

Poster Session 2 - Heart failure

Speakers: Doctor C. Mantis, Doctor N. Sapojnic, Associate Professor Y. Shaposhnikova

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources